American Journal of Managed Care. The emerging role of the type 2 inflammatory cascade in atopic diseases. American Journal of Managed Care. Supplement. Therapeutic Advances in the Management of Type 2 Inflammatory Disease. 2019. (accessed 25 June 2020)

Asthma UK. Asthma facts and statistics. 2018. (accessed 25 June 2020)

Asthma UK Centre for Applied Research. Why is the UK still struggling to significantly improve asthma outcomes? (webinar with Professor Mike Morgan). 2020. (accessed 26 June 2020)

Bateman ED, Reddel HK, O'Byrne PM As-needed budesonide–formoterol versus maintenance budesonide in mild asthma. N Engl J Med.. 2018; 378:(20)1877-1887

Beasley R, Holliday M, Reddel HK Controlled trial of budesonide–formoterol as needed for mild asthma. N Engl J Med.. 2019; 380:(21)2020-2030

Booth A. Prescribing inhaled therapy in asthma: health professionals' habits and beliefs. Journal of Prescribing Practice.. 2020; 2:(4)181-186

British Thoracic Society/Scottish Intercollegiate Guideline Network. BTS/SIGN British guideline on the management of asthma. 2019a. (accessed 25 June 2020)

British Thoracic Society. BTS, SIGN and NICE to produce joint guideline on chronic asthma as part of broader ‘asthma pathway’. 2019b. (accessed 25 June 2020)

British Thoracic Society. Advice for healthcare professionals treating people with asthma (adults) in relation to COVID-19. 2020. (accessed 25 June 2020)

Chauhan BF, Ducharme FM. Addition to inhaled corticosteroids of long-acting beta 2-agonists versus anti-leukotrienes for chronic asthma. Cochrane Database Syst Rev.. 2014; (1)

Global Initiative for Asthma. Global strategy for asthma management and prevention. 2020. (accessed 25 June 2020)

Hardy J, Baggott C, Fingleton J Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial. Lancet. 2019; 394:(10202)919-928

Keeley D, Baxter N. Conflicting asthma guidelines cause confusion in primary care. BMJ. 2018; 360

Rapid response to: Conflicting asthma guidelines cause confusion in primary care. 2018. (accessed 25 June 2020)

NHS England, NHS Improvement. The NHS long term plan. 2019. (accessed 25 June 2020)

Nathan RA, Sorkness CA, Kosinski M Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol.. 2004; 113:(1)59-65

National Asthma Council Australia. Preview to Australian asthma handbook V2.1. 2020. (accessed 30 June 2020)

National Institute for Health and Care Excellence. Asthma: diagnosis, monitoring and chronic asthma management. NICE guideline 80. 2017. (accessed 25 June 2020)

O'Byrne PM, Bisgaard H, Godard PP Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med.. 2005; 171:(2)129-136

O'Byrne PM, FitzGerald JM, Bateman ED Inhaled combined budesonide–formoterol as needed in mild asthma. N Engl J Med.. 2018; 378:(20)1865-1876

Office for National Statistics. Deaths from asthma, respiratory disease, chronic obstructive pulmonary disease and Flu, England and Wales, 2001-2018 occurrences. 2020. (accessed 25 June 2020)

Pavord ID, Wardlaw AJ. The A to E of airway disease. Clin Exp Allergy.. 2010; 40:(1)62-67

Pinnock H, Burton C, Campbell S Clinical implications of the Royal College of Physicians three questions in routine asthma care: a real-life validation study. Prim Care Respir J.. 2012; 21:(3)288-94

Public Health England. Section 8.1 Aerosol generating procedures. 2020. (accessed 29 June 2020)

Primary Care Respiratory Society. PCRS-UK briefing document. Asthma guidelines. 2017. (accessed 25 June 2020)

Primary Care Respiratory Society. PCRS briefing paper. BTS/SIGN British Asthma Guideline update July 2019. 2019. (accessed 25 June 2020)

Rabe KF, Atienza T, Magyar P Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomized controlled, double-blind study. Lancet. 2006; 368:(9537)744-753

Royal College of Physicians. Why asthma still kills. The National Review of Asthma Deaths (NRAD). 2014. (accessed 25 June 2020)

Schatz M, Kosinski M, Yarlas AS, Hanlon J, Watson ME, Jhingran P. The minimally important difference of the Asthma Control Test. J Allergy Clin Immunol.. 2009; 124:(4)719-723.e1

Scicchitano R, Aalbers R, Ukena D Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin.. 2004; 20:(9)1403-1418

Vogelmeier C, D'Urzo A, Pauwels R Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?. Eur Respir J.. 2005; 26:(5)819-828

Asthma guidelines: the best of three

09 July 2020
Volume 29 · Issue 13


National and international guidelines provide evidence-based advice on the diagnosis and management of asthma. There are now three potential asthma guidelines to follow, each taking its own its own unique, and sometimes conflicting direction, creating a total of over 700 pages of high-quality evidence. A puzzle is thus presented to the busy health professional: which guideline do I follow? This article compares and contrasts two national and one international asthma guideline, focusing particularly on diagnosis and pharmacological management. Mortality from asthma is increasing in the UK, making the need for a conjoined guideline more urgent than ever.

Asthma deaths are increasing, despite a plethora of published evidence and guidelines. From a low of 997 deaths in England and Wales in 2009, the number rose to 1392 in 2018 (Office for National Statistics, 2020). In the UK, three people die of asthma every day (Asthma UK, 2018).

The National Review of Asthma Deaths (NRAD) found that there was a lack of health professional knowledge of the UK guidelines in 25% of asthma deaths reviewed. The expert NRAD panels identified factors that could have avoided death in relation to the health professional's implementation of asthma guidelines in 46% of cases, with a specific lack of asthma expertise in 17% of cases (Royal College of Physicians (RCP), 2014). Although it has been alleged that only one of the 19 recommendations from this report have been currently implemented (Levy, 2018), various national initiatives have been taken forward, including the inclusion of respiratory disease in The NHS Long Term Plan (NHS England and NHS Improvement, 2019), changes to the Quality Outcomes Framework, the National Asthma Audit, and guidance for asthma from the National Institute for Health and Care Excellence (Asthma UK Centre for Applied Research, 2020).

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content